The possible role of CD8+/V7.2+/CD161++ T (MAIT) and CD8+/V7.2+/CD161lo T (MAIT-like) cells in the pathogenesis of early-onset pre-eclampsia

ProblemThe objective of this study was to compare the expressions of different immune-checkpoint molecules by MAIT and MAIT-like cells in healthy pregnancy and in early-onset pre-eclampsia. Method of studyPeripheral blood mononuclear cells (PBMC) were stained with monoclonal antibodies to characterize MAIT and MAIT-like cells. Flow cytometric analyses were used to measure PD-1, TIM-3, activation markers, and intracellular perforin expression. ResultsWe identified CD3+/CD8+/V7.2+/CD161++ MAIT cells and a minor cell population characterized by CD3+/CD8+/V7.2+/CD161(lo) surface markers. In measuring the expression of PD-1 receptor, we found a significantly lower expression by MAIT cells in women with early-onset pre-eclampsia. CD69 expression by MAIT cells was significantly elevated in early-onset pre-eclamptic patients. Intracellular perforin content by MAIT and PD-1+ MAIT cells was significantly increased in pre-eclamptic patients compared with healthy individuals. ConclusionAltered frequency and reduced PD-1 expression combined together with the elevated perforin content of MAIT cells insinuate their potential roles in the pathogenesis of early-onset pre-eclampsia.